By Dr. Teri Dourmashkin
In April I posted a entry regarding a letter that Rep. Edward J. Markey (D-MA), chairman of the House Energy and Commerce Subcommittee on Energy and the Environment had sent to the FDA requesting information about the status of their investigation into the widely used chemical, triclosan. The FDA responded by stating that they did not have sufficient safety evidence to warrant changing consumer use of products containing triclosan. Triclosan is an broad spectrum antibacterial which can be found in numerous products including hand soaps, toothpaste, cosmetics, etc. The FDA stated that in some products, the use of triclosan did provide a benefit, however, in the case of antibacterial soaps and body washes, they stated that they did not have evidence that it works any better than soap and water.
The Soap and Detergent Association (SDA) refuted the FDA’s comment regarding triclosan’s ineffectiveness in antibacterial soaps by citing two recent scientific papers demonstrating the effectiveness of antibacterial soaps in comparison to non-antibacterial soaps.
The U.S. Centers for Disease Control and Prevention (CDC) reports an estimated 76 million cases of foodborne illnesses every year in the U.S. The SDA notes that antibacterial soaps play a huge role in the daily hygiene routines of millions of people, and have been used safely and effectively in homes, workplaces and hospitals on a daily basis. They said they look forward to providing Rep. Markey with any relevant updated information regarding the safety of triclosan.
